GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Cyclically Adjusted PS Ratio

Farmaceutica Remedia (BSE:RMAH) Cyclically Adjusted PS Ratio : 0.15 (As of Jun. 10, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Farmaceutica Remedia's current share price is lei0.712. Farmaceutica Remedia's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was lei4.64. Farmaceutica Remedia's Cyclically Adjusted PS Ratio for today is 0.15.

The historical rank and industry rank for Farmaceutica Remedia's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSE:RMAH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.14   Med: 0.16   Max: 0.29
Current: 0.15

During the past years, Farmaceutica Remedia's highest Cyclically Adjusted PS Ratio was 0.29. The lowest was 0.14. And the median was 0.16.

BSE:RMAH's Cyclically Adjusted PS Ratio is ranked better than
81.54% of 65 companies
in the Medical Distribution industry
Industry Median: 0.38 vs BSE:RMAH: 0.15

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Farmaceutica Remedia's adjusted revenue per share data for the three months ended in Dec. 2023 was lei1.805. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is lei4.64 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Farmaceutica Remedia Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Farmaceutica Remedia's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia Cyclically Adjusted PS Ratio Chart

Farmaceutica Remedia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.19 0.14 0.15

Farmaceutica Remedia Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.14 0.15 0.14 0.15

Competitive Comparison of Farmaceutica Remedia's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, Farmaceutica Remedia's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Farmaceutica Remedia's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's Cyclically Adjusted PS Ratio falls into.



Farmaceutica Remedia Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Farmaceutica Remedia's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.712/4.64
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farmaceutica Remedia's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Farmaceutica Remedia's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.805/129.4194*129.4194
=1.805

Current CPI (Dec. 2023) = 129.4194.

Farmaceutica Remedia Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.601 99.695 0.780
201406 0.539 100.560 0.694
201409 0.530 100.428 0.683
201412 0.657 99.070 0.858
201503 0.590 99.621 0.766
201506 0.486 100.684 0.625
201509 0.584 100.392 0.753
201512 0.596 99.792 0.773
201603 0.480 100.470 0.618
201606 0.531 101.688 0.676
201609 0.633 101.861 0.804
201612 0.765 101.863 0.972
201703 0.715 102.862 0.900
201706 0.778 103.349 0.974
201709 0.827 104.136 1.028
201712 1.000 104.011 1.244
201803 0.947 105.290 1.164
201806 1.046 106.317 1.273
201809 1.154 106.507 1.402
201812 1.235 105.998 1.508
201903 1.009 107.251 1.218
201906 0.982 108.070 1.176
201909 1.025 108.329 1.225
201912 1.200 108.420 1.432
202003 1.445 108.902 1.717
202006 0.783 108.767 0.932
202009 1.058 109.815 1.247
202012 1.027 109.897 1.209
202103 1.344 111.754 1.556
202106 0.999 114.631 1.128
202109 1.305 115.734 1.459
202112 1.400 117.630 1.540
202203 1.286 121.301 1.372
202206 1.431 125.017 1.481
202209 1.374 125.227 1.420
202212 1.517 125.222 1.568
202303 1.431 127.348 1.454
202306 1.529 128.729 1.537
202309 1.447 129.860 1.442
202312 1.805 129.419 1.805

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Farmaceutica Remedia  (BSE:RMAH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Farmaceutica Remedia Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmaceutica Remedia (BSE:RMAH) Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines